Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 9(117), p. 1286-1294, 2017
DOI: 10.1038/bjc.2017.294
Links
- ORCID
- ORCID
- Springer Nature [academic journals on nature.com] | PDF
- [hdl.handle.net]
- [eprints.whiterose.ac.uk] | PDF
- [eprints.whiterose.ac.uk] | PDF
- [eprints.whiterose.ac.uk] | PDF
- [eprints.whiterose.ac.uk] | PDF
- [discovery.ucl.ac.uk] | PDF
- [aura.abdn.ac.uk] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.
Journal article published in 2017 by
Simon Gollins,
Nick West,
David Sebag-Montefiore,
Arthur Sun Myint,
Mark P. Saunders,
Shabbir Susnerwala,
Phil Quirke 
,
Sharadah Essapen,
Leslie Samuel,
Bruce Sizer,
Jane Worlding,
Katie Southward,
Gemma Hemmings,
Emma Tinkler-Hundal,
Morag Taylor
and other authors.
,
Sharadah Essapen,
Leslie Samuel,
Bruce Sizer,
Jane Worlding,
Katie Southward,
Gemma Hemmings,
Emma Tinkler-Hundal,
Morag Taylor
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
The influence of EGFR pathway mutations on cetuximab-containing rectal cancer preoperative chemoradiation (CRT) is uncertain.